Kailey Herrera
0009-0003-9552-6784
1 paper found
Refreshing results…
Phase I trial of Ganitumab plus Dasatinib to Cotarget the Insulin-Like Growth Factor 1 Receptor and Src Family Kinase YES in Rhabdomyosarcoma
Missing publications? Search for publications with a matching author name.